Archimedes Pharma ^Partner

Archimedes Pharma is an international specialty pharmaceutical company based in Reading, United Kingdom. Founded in 2004, the company focuses on developing advanced treatments for serious and life-threatening chronic illnesses. It specializes in oncology, pain management, and critical care, utilizing proprietary technologies for nasal and oral drug delivery.

One of Archimedes Pharma's key products is PecFent, a fentanyl Pectin nasal spray designed to manage breakthrough pain in cancer patients. The company has expanded its operations by acquiring specialty products and technologies, as well as developing its own products in-house. Archimedes Pharma has received significant investment to support its growth and has attracted funding from notable investors, including Kyowa Kirin and Warburg Pincus.